FN1 and breast carcinoma: Thus, the reconstitution experiments reported here, where exogenous fibronectin partially reverted the protective effect of tamoxifen ECM on tumour cells in vitro and in a xenograft model of breast cancer, implicate reduced levels of fibronectin as being a signal from the microenvironment that contributes to tumour cell suppression.